Antibodies to human heat-shock protein 60 are associated with the presenceand severity of coronary artery disease - Evidence for an autoimmune component of atherogenesis
Jh. Zhu et al., Antibodies to human heat-shock protein 60 are associated with the presenceand severity of coronary artery disease - Evidence for an autoimmune component of atherogenesis, CIRCULATION, 103(8), 2001, pp. 1071-1075
Citations number
23
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Antibodies to mycobacterial heat-shock protein (HSP) 65 have bee
n reported to be associated with carotid artery thickening. We examined whe
ther antibodies to human HSP60 are associated with the risk of coronary art
ery disease (CAD).
Methods and Results-Blood samples from 391 patients (62% men, mean age 57 y
ears) being evaluated for CAD by coronary angiography were tested for IgG a
ntibodies to human HSP60 by ELISA. We found that 75% of the study subjects
had anti-HSP60 antibodies. The prevalence of CAD was increased in seroposit
ive compared with seronegative patients (68% versus 49%, P=0.0009). Mean ti
ters of HSP60 antibodies were higher in CAD patients than in non-CAD patien
ts (P=0.008). No association between HSP60 antibodies and infection or infl
ammation was found. Importantly, HSP60 antibodies were related to disease s
everity. The prevalence of HSP60 antibodies was 76%, 80%, and 85% in patien
ts with 1-, 2-, and 3-vessel disease, compared with 64% in patients without
CAD (P for trend=0.003). A similar association between increasing antibody
titers and number of diseased vessels was also found (P=0.03). Significant
associations between antibodies to HSP60 and CAD severity persisted after
adjustment for traditional risk factors by age, race, sex, smoking, diabete
s, hypercholesterolemia, hypertension, and C-reactive protein levels. Adjus
ted OR for number of vessels diseased was 1.86 (95% CI 1.13 to 3.04).
Conclusions-This is the first study demonstrating a significant association
between human HSP60 antibodies and both the presence and severity of CAD.